The industry could see payment, workforce and insurance coverage changes depending on how the Trump administration weighs in ...

In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly ...

Eli Lilly, Bristol Myers Squibb, Sanofi and Novartis are seeking to block a major hospital trade group from intervening in court cases over their proposed 340B drug rebate models.

Sanofi has bought back a €3bn ($3.1bn) stake held by cosmetics giant L'Oréal, the first of multiple share buybacks the French drugmaker has planned for 2025. L'Oréal was selling 29,556,650 ...

J&J said its plan to give hospitals rebates instead of upfront discounts on 340B-eligible drugs is necessary to prevent waste and abuse, while hospitals — and the government — maintain the ...